Email Updates

Search form

You are here

Webinar & Meeting Reports

  • May 18, 2015
    Vaccine-O-Licious is an annual event designed to spread the word about HIV Vaccine Awareness Day. The event brought together a variety of performers uniting through dance and song. Peppermint hosted this exciting evening of entertainment, with a little education too!
  • May 18, 2015

    GHTC and COHRED discussed in a webinar approaches to achieving access to new products, and how those approaches can impact the R&D process. The discussion included multiple perspectives on the topic and a Q&A with the panelists.

  • May 18, 2015

    On May 18, advocates around the world observed HIV Vaccine Awareness Day (HVAD)—an annual commemoration of the need for and commitment to the ongoing search for a vaccine. AVAC convened a webinar—Vaccines in Vivo: Advances in AIDS Vaccine Research—and updated a number of materials, including our “HVAD Toolkit” for those interested in easy-to-digest research updates.

  • May 18, 2015

    On May 18 every year, HIV prevention advocates around the world raise their voices about the urgent need to continue the search for a safe and effective AIDS vaccine, and especially to recognize the enormous contribution of the thousands of volunteers who have participated in vaccine trials, without which this research would not be possible. Here is a partial list of events that happened all around the world.

  • April 28, 2015
    IRMA and AVAC hosted this webinar on rectal agents in development, including the antiretroviral drug Dapivirine and Griffithsin, a potent, anti-HIV protein derived from red algae. We also learned about exciting plans for developing new microbicide formulations like rectal douches.
  • April 21, 2015

    This webinar focused on “passive immunization”—a scientific term for an expanding area of research that’s highly relevant to treatment, prevention and cure work. There are trials in humans happening in many regions of the world—and data are beginning to come in that advocates need to understand, analyze and consider.

    The webinar featured Dr. Sarah Schlesinger (Rockefeller University) who provided an overview of recent developments across the field including new published data.

  • April 14, 2015

    In this webinar, Raphael Landovitz, Protocol Chair, presented on HPTN 077—a Phase IIa safety, tolerability and acceptability study of an investigational injectable HIV integrase inhibitor, GSK1265744, for PrEP in HIV uninfected men and women. It is currently enrolling HIV uninfected men and women at low to minimal risk for acquiring HIV infection, ages 18 to 65.

  • March 13, 2015

    The MTN 2015 Annual Meeting was held at the Bethesda North Marriott Hotel & Conference Center; 5701 Marinelli Road, North Bethesda, MD 20852. The meeting dates were from March 13, 2015 through March 18, 2015. 

  • March 12, 2015

    This webinar featured Jean-Michel Molina of the French research agency ANRS and Sheena McCormack of the UK Medical Research Council discussing the data from the IPERGAY and PROUD studies, respectively. Both trials evaluated oral TDF/FTC (brand name Truvada) as PrEP in gay men and other men who have sex with men, and both reported high levels of protection against HIV acquisition.

  • March 11, 2015

    This webinar featured Wafaa El-Sadr, principal investigator of HPTN 065, which evaluated the use of cash incentives in improving outcomes for people living with HIV in the United States.

Pages